AMR Davos Compact 2025

4 global initiatives, the GLG, the MSPP and patient -focused groups, including those representing non -communicable diseases that are impacted by AMR. • Working where possible with consumers, producers, food companies and patients to ensure full understanding of the One -Health nature of AMR. Demand good infection prevention control, appropriate stewardship, vaccination in the healthcare sector and appropriate use across the food chain . Sustainable A gri-Food Systems Through public private partnerships, collaboration within relevant initiatives and a network of best practice sharing - facilitate innovation and preventative actions to enable the target ed reduction of antimicrobial use particularly aimed at stopping non- veterinary medical uses, such us growth promotion or routine use for prophylaxis, starting with those m edically important for human medicine . • Collaborate with, and support , the RENOF ARM (Reduce the Need for Antimicrobials on Farms for Sustainable Agrifood Systems Transformation ) initiative . • Facilitat e partnerships to invest in innovation and promote alternatives to antimicrobials and increasing implementation of stewardship guidance and biosecurity in the animal and food industry, foster behavio ur change to antimicrobial use, and preventive measures such as better bio -security, good husbandry practices, stewardship, WASH and IPC, including vectors. • Building on the work initiated by investor groups to improve the stewardship of anti microbials in supply chains. • Improving innovation and access to diagnostic s. • Facilitate investor action to support the action required for guidelines for appropriate antimicrobial use and disposal, across the food chain. • Encourage support for local farmers with the available financial , educational and technical resources needed to transition toward sustainable practices. Prioritizing prevention to reduce animal disease burden and therefore the need to use antimicrobials, whilst maintaining productivity and food security and reducing the release of antimicrobials and AMR pathogens into the environment. Promoting Multisec toral Engagement and Funding • Support the Quadripartite Joint Secretariat on AMR, working with the World Bank , with mapping existing and catalytic funding, to clarify and facilitate access to appropriate and available funds for AMR (e.g., via existing global health initiatives , such as the AMR Multi -